Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s480, 2024. DOI: 10.25251/skin.8.supp.480. Disponível em: https://skin.dermsquared.com/skin/article/view/3040. Acesso em: 19 may. 2025.